Oncotarget

A research paper published in Oncotarget Volume 17 identifies CREB-5 as a master regulator of stem cell-like programs in prostate cancer progression.

Oncotarget published a new editorial in Volume 17 analyzing the journal's approach to scientific integrity.

Oncotarget Editor-in-Chief Wafik El-Deiry will chair the 2025 WIND Symposium as part of the Advancing Precision Medicine conference in Philadelphia, featuring global oncology leaders and multi-omics integration.

A new study reveals that epigenetic dysregulation of the PDX1 gene promotes prostate cancer progression by enhancing cell proliferation and regulating key metabolic and EMT pathways.

This episode discusses a new review published in Oncotarget that examines the critical neglect of cancer care in conflict zones and humanitarian settings, highlighting structural barriers and advocating for policy integration.

This episode discusses a research paper identifying CREB5 as a master regulator driving stem cell-like programs in prostate cancer progression, particularly in therapy-resistant tumors.

A systematic review and meta-analysis finds that adjuvant PD-1/PD-L1 inhibitors improve disease-free and distant metastasis-free survival in solid cancers but come with increased adverse events requiring careful monitoring.

This episode discusses a recent review that uses bibliometric network analysis to map the evolution of glioma classification research across clinical, molecular, and social domains, identifying influential papers and thematic gaps.

A new study published in Oncotarget shows that combining the SCD1 inhibitor Aramchol with regorafenib and metformin effectively kills uveal melanoma and cholangiocarcinoma cells by enhancing autophagic flux and death receptor signaling.

This episode reviews a scientific case report investigating potential links between mRNA COVID-19 vaccinations and the development of hematopoietic cancers, focusing on a specific patient case.

A new study reveals that folate receptor beta is widely expressed in pediatric solid tumors, offering a potential target for improving surgical accuracy using the fluorescent agent paphylationine.

Oncotarget Editor-in-Chief Wafik El-Deiry will chair the 2025 WIND Symposium as part of the Advancing Precision Medicine conference in Philadelphia, featuring global oncology leaders and multi-omics integration to accelerate clinical translation.